|
Ophthalmology1985;92(1):167173
9纪小龙，施作霖.诊断免疫组织化学.第1版.北京：军事医学科学出版社1997:8692
10易玉珍，杨为中，郑湖铃.视网膜母细胞瘤的细胞来源与分化研究.中华眼科杂志1994;30(3):214217
11毛羽翔，杨华胜.神经元特异性烯醇化酶检测在眼科的临床意义.国外医学眼科分册1997;21(2):120123
12 Molnar ML, Stefansson K, Marton LS, et al. Immunohistochemistry of retinoblastoma in Human. Am J Ophthalmol1984;97(3):301307
13 Perentes E, Herbort CP, Rubinstein LJ, et al. Immunohistochemical characterization of human retinoblastoma in Situ with multiple markers.
Ophthalmology1987;103(5):647 658
14 Rodrigues MM, Wiggert B, Shields J, et al. Retinoblastoma：immunohistochemistry and cell differentiation. Ophthalmology1987;94:378387
15 Kivela R. Neuron specific enolase in retinoblastoma：an immunohistochemical study. Acta Ophthalmol1986;64(1):1925
16 He W, Hashimoto N, Tsuneyoshi M, et al. A reassessment of histologiC classification and an immunohistochemical study of 88 ret ionblastomas. Cancer1992;70(12):29012908
17 Yuge K, Nakajima M, Uemura Y, et al. Immunohistochemical features of the human retina and retinoblastoma. Virchows Arcb1995;426(6):571575
18 Bishop AE, Carlei F, Lee V, et al. Combined immunostaining of neurofilaments, neuron specific enolase, GFAP and S100. A possible means for assessing the morphological and functional status of the enteric nervous system. Histochemistry1985;82(1):9397
19 Schorder HD. Immunohistoehemical demonstration of glial markers in retinoblastomas. Virchows Arch A Pathol Anat Histopathol1987;411(1):6772
20 De Guevara R，Pairault C，Pinganaud G．Expression of vimentinand GFAP and development of the retina in the trout. C R Acad Sci III1994;317(8):737741
21 Shields JA, Shields CS. Intraocular Tumors．Philadelphina：WBSaunders1992:305392
22盛讯伦,王娟,郭慧,等.国人视网膜母细胞瘤患者RBI基因突变的特征.国际眼科杂志2006;6(1):7577
23 Mastrangelo D, Squitieri N, Bruni S, et al. The polymerase chain reaction (PCR) in the routine genetic characterization of retinoblastoma：a tool for the clinical laboratory. Surv Ophthalmol1997;4l(4):331340
24 Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properities of the gene that predispose to retinoblastoma. Nature1986;323(6089)：643 646
25黄倩.视网膜母细胞瘤P53基因存在状态的研究.中华眼科杂志1999;35(4):24825l
26黄倩，Thaddeus P，Dryja David W, et al. RB患者及家庭成员RB基因突变和患病风险的基因诊断及遗传咨询.中华医学遗传学杂志1998;15(2):65 68
27吴中耀，杨华胜，陈智聪,等.视网膜母细胞瘤的激光、冷冻和放射治疗.中华眼病杂志1996;12(1):48 49
28曾一平，张晓农.视网膜母细胞瘤的临床病理及预后.中国实用眼科杂志1997;15(2):99101
29杨敬林，汪湘琳，陶永贤．视网膜母细胞瘤术后存活20年以上下的随访观察.中国实用眼科杂志1998;15(5)：269271
30 Shields CL, Shields JA. Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus1999; 36(1):818
31杨红, Schilling H, Effect R,等. 297例视网膜母细胞瘤的临床病理研究.中华眼科杂志1999;35(4):255257
32 Karim MM, Yamamoto M, Itoh H. Retinoblastoma：elinical and immunocytochemical observations. Med Sci1996;42(3):151161
33李大宇，宋绣雯，高银娥,等.增殖细胞核抗原及核仁组成区嗜银蛋白与视网膜母细胞瘤预后的关系.中华眼科杂志1997;33(4):293296
34杨相军,张振国.视网膜母细胞瘤P53、cmyc及增殖细胞核抗原表达的研究.中华眼科杂志1999;35(4):252254
35毛健,孙宪丽,田玉旺.视网膜母细胞瘤瘤细胞凋亡分子病理学及自发退化机制研.中华眼科杂志1996;32(6):405 409
36盛讯伦,吴伟民,庄文娟,等.视网膜母细胞瘤患者RBI基因突变筛选.国际眼科杂志2005;5(2):243245
上一页 [1] [2] [3] |
